NEUROMUSCULAR SAFETY MARGIN: GENETICAL, IMMUNOLOGICAL AND ELECTROPHYSIOLOGICAL DETERMINANTS IN RELATIVES OF MYASTHENIC PATIENTS: A PRELIMINARY REPORT